These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 34370608)
1. VMAT2 Inhibitors for the Treatment of Tardive Dyskinesia. Warren B; Vanderhoef D; Johnson J Issues Ment Health Nurs; 2022 Jan; 43(1):22-31. PubMed ID: 34370608 [TBL] [Abstract][Full Text] [Related]
2. Valbenazine for the treatment of tardive dyskinesia. Seeberger LC; Hauser RA Expert Opin Pharmacother; 2017 Aug; 18(12):1279-1287. PubMed ID: 28699794 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors. Niemann N; Jankovic J Drugs; 2018 Apr; 78(5):525-541. PubMed ID: 29484607 [TBL] [Abstract][Full Text] [Related]
5. Valbenazine as the first and only approved treatment for adults with tardive dyskinesia. Sarva H; Henchcliffe C Expert Rev Clin Pharmacol; 2018 Mar; 11(3):209-217. PubMed ID: 29338466 [TBL] [Abstract][Full Text] [Related]
6. The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder. McIntyre RS; Calabrese JR; Nierenberg AA; Farahmand K; Yonan C; Siegert S; Burke J J Affect Disord; 2019 Mar; 246():217-223. PubMed ID: 30583148 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder. Josiassen RC; Kane JM; Liang GS; Burke J; O'Brien CF Psychopharmacol Bull; 2017 Aug; 47(3):61-68. PubMed ID: 28839341 [TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients. Witter DP; Holbert RC; Suryadevara U Expert Opin Pharmacother; 2017 Jul; 18(10):965-972. PubMed ID: 28443349 [TBL] [Abstract][Full Text] [Related]
20. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs]. Seigneurie AS; Sauvanaud F; Limosin F Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]